kabutan

ASKA Pharmaceutical rises for a 4th consecutive day to a fresh yearly high on increased stake by UK-based Nippon Active Value Fund

Thu Apr 9, 2026 10:52 am JST Catalyst

ASKA Pharmaceutical Holdings <4886> extended gains for a fourth consecutive session, hitting a fresh year-to-date high. After the close of trading on the 8th, it was disclosed that the combined shareholding of UK-based Nippon Active Value Fund and its joint holders increased from 20.49% to 21.32%, attracting speculative buying interest. According to the amended large shareholding report filed with the Kanto Local Finance Bureau, the reporting obligation date was April 1st. The stated purpose of holding is "investment, provision of management advice to the management team, and, depending on circumstances, implementation of significant proposals."

Source: MINKABU PRESS

*Translated by generative AI. Click here for the original article.

Related Articles